Similar articles for PMID: 17699258

Year	Number of Results
1975	1
1976	1
1978	1
1979	2
1982	1
1984	1
1985	1
1988	1
1989	1
1991	1
1993	1
1994	1
1996	2
1997	1
1999	2
2000	2
2001	3
2002	2
2003	7
2004	4
2005	6
2006	9
2007	6
2008	12
2009	8
2010	10
2011	12
2012	15
2013	11
2014	14
2015	18
2016	13
2017	8
2018	10
2019	12
2020	14
2021	0

1

Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation.

Ruggenenti P, Codreanu I, Cravedi P, Perna A, Gotti E, Remuzzi G. Ruggenenti P, et al. Clin J Am Soc Nephrol. 2006 May;1(3):546-54. doi: 10.2215/CJN.01841105. Epub 2006 Mar 1. Clin J Am Soc Nephrol. 2006. PMID: 17699258 Free article. Clinical Trial.

2

Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation.

Pilch NA, Taber DJ, Moussa O, Thomas B, Denmark S, Meadows HB, McGillicuddy JW, Srinivas TR, Baliga PK, Chavin KD. Pilch NA, et al. Ann Surg. 2014 May;259(5):888-93. doi: 10.1097/SLA.0000000000000496. Ann Surg. 2014. PMID: 24513787 Clinical Trial.

3

Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection.

Deeks ED, Keating GM. Deeks ED, et al. Drugs. 2009 Jul 30;69(11):1483-512. doi: 10.2165/00003495-200969110-00007. Drugs. 2009. PMID: 19634926 Review.

4

Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.

Flaman F, Zieroth S, Rao V, Ross H, Delgado DH. Flaman F, et al. J Heart Lung Transplant. 2006 Nov;25(11):1358-62. doi: 10.1016/j.healun.2006.09.002. J Heart Lung Transplant. 2006. PMID: 17097501 Clinical Trial.

5

Low-dose RATG with or without basiliximab in renal transplantation: a matched-cohort observational study.

Gentile G, Somma C, Gennarini A, Mastroluca D, Rota G, Lacanna F, Locatelli B, Remuzzi G, Ruggenenti P. Gentile G, et al. Am J Nephrol. 2015;41(1):16-27. doi: 10.1159/000371728. Epub 2015 Jan 23. Am J Nephrol. 2015. PMID: 25612603

6

Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience.

Huang HF, Zhou JY, Xie WQ, Wu JY, Deng H, Chen JH. Huang HF, et al. Int Urol Nephrol. 2016 Aug;48(8):1363-1370. doi: 10.1007/s11255-016-1307-y. Epub 2016 May 11. Int Urol Nephrol. 2016. PMID: 27170340 Clinical Trial.

7

Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up.

Laftavi MR, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S, Pankewycz O. Laftavi MR, et al. Transplant Proc. 2011 Mar;43(2):458-61. doi: 10.1016/j.transproceed.2011.01.035. Transplant Proc. 2011. PMID: 21440733

8

Comparison of sequential protocol using basiliximab versus antithymocyte globulin with high-dose mycophenolate mofetil in recipients of a kidney graft from an expanded-criteria donor.

Pallet N, Anglicheau D, Martinez F, Mamzer MF, Legendre C, Thervet E. Pallet N, et al. Transplantation. 2006 Mar 27;81(6):949-52. doi: 10.1097/01.tp.0000198417.91135.1f. Transplantation. 2006. PMID: 16570022

9

Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial.

Carrier M, Leblanc MH, Perrault LP, White M, Doyle D, Beaudoin D, Guertin MC. Carrier M, et al. J Heart Lung Transplant. 2007 Mar;26(3):258-63. doi: 10.1016/j.healun.2007.01.006. J Heart Lung Transplant. 2007. PMID: 17346628 Clinical Trial.

10

Basiliximab: a review of its use as induction therapy in renal transplantation.

Chapman TM, Keating GM. Chapman TM, et al. Drugs. 2003;63(24):2803-35. doi: 10.2165/00003495-200363240-00009. Drugs. 2003. PMID: 14664658 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed